COGT Insider Trading

Insider Ownership Percentage: 5.92%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Cogent Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Cogent Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$5M$0$5MTotal Insider BuyingTotal Insider Selling

Cogent Biosciences Share Price & Price History

Current Price: $5.72
Price Change: Price Decrease of -0.07 (-1.21%)
As of 04/2/2025 05:00 PM ET

This chart shows the closing price history over time for COGT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$5.79Closing price on 04/01/25:

Cogent Biosciences Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Cogent Biosciences (NASDAQ:COGT)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at COGT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$87Mbought$54MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$50M$0$50MTotal InflowsTotal Outflows
Cogent Biosciences logo
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Read More on Cogent Biosciences

Today's Range

Now: $5.72
Low: $5.48
High: $5.93

50 Day Range

MA: $7.78
Low: $5.79
High: $9.66

52 Week Range

Now: $5.72
Low: $5.48
High: $12.61

Volume

1,701,348 shs

Average Volume

1,244,844 shs

Market Capitalization

$651.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.8

Who are the company insiders with the largest holdings of Cogent Biosciences?

Cogent Biosciences' top insider shareholders include:
  1. Fairmount Funds Management Llc (Major Shareholder)
Learn More about top insider investors at Cogent Biosciences.